Table 1:

Subject demographic and clinical informationa

HC (n = 19)IPD (n = 19)Between Groups
BLF/UBLF/UP Value within BLP Value within F/U
Age (yr)56.5 (10.1)59.6 (10.3)59.8 (8.4)63.2 (8.4).276.251
Male sex (No.) (%)5 (26)12 (63).022
Disease duration (yr)7.1 (5.1)10.4 (5.3)
Time to F/U (mo)36.2 (5.4)43.8 (7.8).001
MMSE score29.4 (0.9)29.5 (0.9)29.4 (1.0)27.6 (4.8).586.862
MoCA score27.3 (2.4)27.9 (2.1)24.4 (4.2)24.3 (6.9).095.046
CDR score (mean, median) (IQR)0, 0 (0–0)0.1, 0 (0–0)0.2, 0 (0–0.5)0.3, 0 (0–0.5).053.317
UPDRS-III score0.8 (1.2)1.3 (2.3)18.8 (7.3)22.1 (9.2)<.001<.001
H&Y (mean, median) (IQR)0, 0 (0–0)0, 0 (0)1.9, 2 (1–2.5)2.4, 2.5 (2–3)<.001<.001
S&E score100 (0)100 (0)91.3 (9.3)79.5 (21.8).001.001
GDS score1.9 (2.9)1.2 (1.9)2.3 (2.1)5.2 (7.9).615.044
  • Note:—H&Y indicates Hoehn and Yahr scale; S&E, Schwab and England Activities of Daily Living Scale; GDS, Geriatric Depression Scale; IQR, interquartile range; BL, baseline; F/U, follow up; CDR, Clinical Dementia Rating; UPDRS III, Unified Parkinson's Disease Rating Scale, Part III.

  • a Results are presented as mean (SD), unless otherwise noted.